Anna M. Sandqvist

Solna, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension.

Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension.

Journal: ESC heart failure

Published: January 26, 2022

Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival.

Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival.

Journal: Scandinavian cardiovascular journal : SCJ

Published: June 27, 2020

Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Journal: ERJ open research

Published: May 23, 2020

Alterations in plasma L-arginine and methylarginines in heart failure and after heart transplantation.

Alterations in plasma L-arginine and methylarginines in heart failure and after heart transplantation.

Journal: Scandinavian cardiovascular journal : SCJ

Published: April 13, 2018

Plasma L-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction.

Plasma L-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction.

Journal: Heart and vessels

Published: May 08, 2017

Acute vasodilator response to vardenafil and clinical outcome in patients with pulmonary hypertension.

Acute vasodilator response to vardenafil and clinical outcome in patients with pulmonary hypertension.

Journal: European journal of clinical pharmacology

Published: May 11, 2015

Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension.

Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension.

Journal: Vascular pharmacology

Published: January 04, 2015

Acute haemodynamic response in relation to plasma vardenafil concentrations in patients with pulmonary hypertension.

Acute haemodynamic response in relation to plasma vardenafil concentrations in patients with pulmonary hypertension.

Journal: British journal of clinical pharmacology

Published: April 21, 2012

High inter-individual variability of vardenafil pharmacokinetics in patients with pulmonary hypertension.

High inter-individual variability of vardenafil pharmacokinetics in patients with pulmonary hypertension.

Journal: European journal of clinical pharmacology

Published: January 20, 2012

Preoperative withdrawal of drugs that affect hemostasis. Evidence-based recommendation

Preoperative withdrawal of drugs that affect hemostasis. Evidence-based recommendation

Journal: Lakartidningen

Published: November 04, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026